Optimizing antimicrobial pharmacodynamics: dosage strategies for meropenem
- 1 August 2004
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 26 (8) , 1187-1198
- https://doi.org/10.1016/s0149-2918(04)80001-8
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Relationship between Fluoroquinolone Area under the Curve:Minimum Inhibitory Concentration Ratio and the Probability of Eradication of the Infecting Pathogen, in Patients with Nosocomial PneumoniaThe Journal of Infectious Diseases, 2004
- Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for MeropenemThe Journal of Clinical Pharmacology, 2003
- Comparison of the pharmacodynamics of meropenem in healthy volunteers following administration by intermittent infusion or bolus injectionJournal of Antimicrobial Chemotherapy, 2003
- Tissue Penetration by Ertapenem, a Parenteral Carbapenem Administered Once Daily, in Suction-Induced Skin Blister Fluid in Healthy Young VolunteersAntimicrobial Agents and Chemotherapy, 2003
- Pharmacokinetics of High-Dose Meropenem in Adult Cystic Fibrosis PatientsChemotherapy, 2001
- Comparative Pharmacokinetics of the CarbapenemsClinical Pharmacokinetics, 2000
- The Pharmacodynamics of β‐LactamsClinical Infectious Diseases, 1998
- Continuous Infusion of ??-Lactam AntibioticsClinical Pharmacokinetics, 1998
- Meropenem Clinical PharmacokineticsClinical Pharmacokinetics, 1995
- Pharmacokinetics of meropenem in serum and suction blister fluid during continuous and intermittent infusionJournal of Antimicrobial Chemotherapy, 1991